The hazards of randomized phase II trials
- PMID: 22190670
- DOI: 10.1093/annonc/mdr567
The hazards of randomized phase II trials
Erratum in
- Ann Oncol. 2012 Mar;23(3):810
Comment on
-
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.Ann Oncol. 2012 Jan;23(1):72-77. doi: 10.1093/annonc/mdr030. Epub 2011 Apr 4. Ann Oncol. 2012. PMID: 21464154 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical